Alkem Laboratories Limited Stock Analysis
ALKEMLatest Share Price
Research Score
Why This Score
- Strong price momentum, trading within 5% of its 52-week high.
- Healthy ROE above 15%, showing consistent value creation.
- Conservative capital leverage with comfortable debt coverage.
Overall Health
Key Metrics
This is the current market price of one share on the NSE.
This is the total market value of the company's outstanding shares.
This is the highest price the stock reached in the past year.
This is the lowest price the stock reached in the past year.
This shows how much investors are paying for every ₹1 of company earnings.
This compares the market price to the net assets (book value) of the company.
This measures how efficiently the company generates profit from capital.
This measures the profitability of the company in relation to the shareholders' equity.
This indicates how much debt the company uses compared to shareholder funds.
This is the year-on-year growth rate of company net profits.
This is the year-on-year growth rate of company revenues.
This shows the percentage of sales remaining after direct operating costs.
This is the annual dividend payout relative to the share price.
This shows the percentage of equity held by company founders.
This indicates the percentage of promoter shares pledged as collateral.
This compares recent trading volume to the long-term average.
Financial Education Center
Strengths
- Strong bullish price momentum
- Solid return on equity
Weaknesses
- Contracting quarterly profit margins
About the Company
Company Overview
Alkem Laboratories Limited is a leading enterprise operating in the Indian stock market (NSE: ALKEM), with a primary business focus on Drug Manufacturers - Specialty & Generic. As a vital player in the Healthcare sector, the company has built a robust market presence, catering to a diverse client base across domestic and international markets. It plays a critical role in driving innovation and commercial growth in its field.
Business Segments
The operations of Alkem Laboratories Limited are structured across multiple specialized business segments. Its primary division handles core manufacturing, service pipelines, and distribution network design for Drug Manufacturers - Specialty & Generic solutions. By diversifying its segments, the firm manages operational risks while maintaining stable revenue flows even during cyclical market downturns.
Products and Services
The company provides professional products and consumer services in the Drug Manufacturers - Specialty & Generic domain. These include institutional contracts, retail goods, and bespoke consulting services engineered specifically for the requirements of the Indian market. The brand is recognized for reliability, technological integration, and quality assurance.
Industry Overview
The Indian Healthcare industry is experiencing rapid modernization, propelled by structural reforms, digital transformation, and rising commercial consumption. Alkem Laboratories Limited is strategically positioned to benefit from these tailwinds by scaling capacity, optimizing supply chains, and adopting modern technologies to satisfy rising consumer demand.
Competitive Position
In terms of competitive positioning, Alkem Laboratories Limited stands out among Nifty 500 peers due to its distribution scale, intellectual property, and financial strength. It competes with major domestic and international players by focusing on cost efficiency, strong customer relationships, and continuous service upgrades to maintain its market leadership.
Frequently Asked Questions
What does Alkem Laboratories Limited do?
Alkem Laboratories Limited is a leading company on the National Stock Exchange (NSE: ALKEM), specializing in Drug Manufacturers - Specialty & Generic solutions within the Healthcare sector.
Is Alkem Laboratories Limited profitable?
According to its latest financials, the company has an operating margin of 10.82% and reported net profit growth of -22.70%.
What sector is Alkem Laboratories Limited in?
Alkem Laboratories Limited operates in the Healthcare sector, primarily under the Drug Manufacturers - Specialty & Generic industry classification.
What is Alkem Laboratories Limited's PE Ratio?
The current Price to Earnings (P/E) ratio of the stock is 29.80x. This indicates how much investors are paying per rupee of earnings.
Why does Alkem Laboratories Limited have this research score?
Alkem Laboratories Limited has a StockScore of 44/100, which is classified as Weak. This score is dynamically computed based on momentum, capital efficiency, leverage, and growth metrics.
How often is this page updated?
Share prices are updated dynamically, while fundamental ratios, research scores, strengths, and weaknesses are refreshed daily following the latest stock exchange filings.
Can beginners use this research?
Absolutely. StockScore is designed to translate complex balance sheets and income statements into a single, intuitive score and clear pro/con lists that any retail investor can understand in 30 seconds.